Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial

Evaldo Favi, Nicola Silvestrini, Gionata Spagnoletti, Marco Castagneto, Franco Citterio

Risultato della ricerca: Contributo in rivistaContributo a convegno

Fingerprint

Entra nei temi di ricerca di 'Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial'. Insieme formano una fingerprint unica.

Medicine and Dentistry

Immunology and Microbiology